OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits
Henrieta Scholtzova, Eileen Do, Shleshma Dhakal, et al.
Journal of Neuroscience (2016) Vol. 37, Iss. 4, pp. 936-959
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Microglia in Alzheimer’s disease
Heela Sarlus, Michael T. Heneka
Journal of Clinical Investigation (2017) Vol. 127, Iss. 9, pp. 3240-3249
Open Access | Times Cited: 735

Rodent models for Alzheimer disease
Jürgen Götz, Liviu‐Gabriel Bodea, Michel Goedert
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 10, pp. 583-598
Closed Access | Times Cited: 304

TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Junling Yang, Leslie Wise, Ken‐ichiro Fukuchi
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 275

Priming Microglia for Innate Immune Memory in the Brain
Jonas J. Neher, Colm Cunningham
Trends in Immunology (2019) Vol. 40, Iss. 4, pp. 358-374
Closed Access | Times Cited: 190

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Dawling A. Dionisio-Santos, John A. Olschowka, M. Kerry O’Banion
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 150

Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
Claire Vanpouille‐Box, Jules A. Hoffmann, Lorenzo Galluzzi
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 11, pp. 845-867
Closed Access | Times Cited: 149

Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration
Fangjie Shao, Xiaoyu Wang, Haijian Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 141

Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 21

Neuroinflammatory responses in Alzheimer’s disease
Cira Dansokho, Michael T. Heneka
Journal of Neural Transmission (2017) Vol. 125, Iss. 5, pp. 771-779
Closed Access | Times Cited: 126

Microbiota-gut-brain axis and toll-like receptors in Alzheimer’s disease
Caixiu Lin, Shuai Zhao, Yueli Zhu, et al.
Computational and Structural Biotechnology Journal (2019) Vol. 17, pp. 1309-1317
Open Access | Times Cited: 77

Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions
Silvia Squillace, Daniela Salvemini
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 726-739
Open Access | Times Cited: 56

NGF steers microglia toward a neuroprotective phenotype
Caterina Rizzi, Alexia Tiberi, Michela Giustizieri, et al.
Glia (2018) Vol. 66, Iss. 7, pp. 1395-1416
Open Access | Times Cited: 83

Luteolin Could Improve Cognitive Dysfunction by Inhibiting Neuroinflammation
Zhaohui Yao, Xiaoli Yao, Yong Zhang, et al.
Neurochemical Research (2018) Vol. 43, Iss. 4, pp. 806-820
Closed Access | Times Cited: 69

Complement System in Alzheimer’s Disease
Akash Shah, Uday Kishore, Abhishek Shastri
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13647-13647
Open Access | Times Cited: 55

Toll-like receptors in Alzheimer's disease
Sara Momtazmanesh, George Perry, Nima Rezaei
Journal of Neuroimmunology (2020) Vol. 348, pp. 577362-577362
Closed Access | Times Cited: 51

FDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness
Elisa Canepa, Rebecca Parodi‐Rullán, Rafael Vázquez‐Torres, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 5048-5073
Open Access | Times Cited: 22

Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Giacoma Galizzi, Marta Di Carlo
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8586-8606
Open Access | Times Cited: 18

Common Signaling Pathways Involved in Alzheimer’s Disease and Stroke: Two Faces of the Same Coin
Tushar Kanti Das, Bhanu Priya Ganesh, Kaneez Fatima-Shad
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 381-398
Open Access | Times Cited: 17

Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia
Charles L. Greenblatt, Richard Lathe
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 2, pp. 361-372
Open Access | Times Cited: 6

Tolerance-inducing effect and properties of innate immune stimulation on chronic stress-induced behavioral abnormalities in mice
Yue Gu, Ting Ye, Pingping Tan, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 451-471
Closed Access | Times Cited: 45

Alzheimer’s disease and immunotherapy
Wei Qin, Yana Pang, Shuya Nie, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6

Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains
Douglas G. Walker, Tiffany M. Tang, Lih‐Fen Lue
Experimental Neurology (2018) Vol. 309, pp. 91-106
Open Access | Times Cited: 46

Page 1 - Next Page

Scroll to top